Nivaquine Tablet

About Nivaquine 250 mg Tablet

Nivaquine is a brand of Chloroquine Phosphate, an anti-malarial medicine in tablet form. It is used to treat and prevent malaria and certain other conditions, but a doctor decides if it is right for you.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Nivaquine 250 mg Tablet?

Nivaquine 250 mg tablet is an anti-malarial medicine containing Chloroquine Phosphate. It is used for treating malaria, preventing malaria, and managing amoebic hepatitis and abscess. It is also used for discoid and systemic lupus erythematosus and rheumatoid arthritis. This medicine works against malaria parasites in the blood and has effects in other conditions. It is available by prescription, and the doctor decides the appropriate dose and course for each person. Always follow medical advice and do not self-medicate.

Uses of Nivaquine

Nivaquine is used to treat malaria and to prevent it. It is also used for amoebic hepatitis and amoebic abscess, and for discoid and systemic lupus erythematosus and rheumatoid arthritis. The doctor determines if this medicine is suitable for your condition and will decide the dose and duration of treatment.

How to use Nivaquine

Take Nivaquine exactly as your doctor prescribes. The dose and course depend on your condition, age, and other factors, so the doctor will decide. Swallow the tablet with water. Do not change the dose or stop treatment without medical advice. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Nivaquine

Nivaquine is usually well tolerated at standard doses. Common side effects include headache and stomach upset. Prolonged use at high doses may cause skin eruptions, hair loss, vision problems, and rarely blood disorders. Serious eye damage can occur with long-term use. Tell your doctor if you notice any side effects.

Safety and precautions

Before taking Nivaquine, tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. It should be avoided in pregnancy unless the doctor decides the benefit outweighs the risk. Caution is needed in patients with porphyria, liver problems, or in alcoholics. Long-term use requires regular eye check-ups. Ask your doctor if you have any health conditions or are taking other medicines.

Frequently asked questions

How should I store Nivaquine?

Store Nivaquine at room temperature in a dry place, away from light. Keep it out of reach of children. Do not use after the expiry date. Ask your pharmacist if you are unsure about storage conditions.

What is Nivaquine used for and what kind of medicine is it?

Nivaquine is an anti-malarial medicine containing Chloroquine Phosphate. It is used to treat and prevent malaria, and also for amoebic hepatitis, lupus, and rheumatoid arthritis. It is available only with a doctor's prescription.

What does the generic name Chloroquine Phosphate mean?

Chloroquine Phosphate is the active ingredient in Nivaquine. It belongs to a group of medicines called anti-malarials. Chloroquine works against malaria parasites in the blood and also has effects in other inflammatory conditions.

Can I take Nivaquine without a doctor's advice?

No, Nivaquine should only be taken when prescribed by a doctor. The dose and course are decided by the doctor based on your condition. Self-medication can be dangerous, especially with long-term use.

Also available as

80 mg/5 ml (Syrup)

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.